Evidence map›Paper›PMID 32010303›Full record

ArticleExperimental and therapeutic medicine2020

Effect of pulegone on the NLPR3 inflammasome during inflammatory activation of THP-1 cells.

Qingxin Yang, Qi Liu, Hongjun Lv, Feng Wang, Rong Liu, Nan Zeng

Open access · diamondAbstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Endocrine, metabolic & immune disorders drug targets · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Subcritical Water Extraction ofMolecules (Basel, Switzerland) · 2023
    Article
  11. Article
  12. Benzyl Isothiocyanate Attenuates Inflammasome Activation inInternational journal of molecular sciences · 2022
    Article
  13. Screening of the Potential Bioactivities of Pennyroyal (Antibiotics (Basel, Switzerland) · 2021
    Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Qingxin YangDepartment of Pharmacology, College of Pharmacy, Chengdu University of TCM, Chengdu, Sichuan 611137, P.R. China.
Qi LiuDepartment of Pharmacology, College of Pharmacy, Chengdu University of TCM, Chengdu, Sichuan 611137, P.R. China.
Hongjun LvDepartment of Pharmacology, College of Pharmacy, Chengdu University of TCM, Chengdu, Sichuan 611137, P.R. China.
Feng WangDepartment of Pharmacology, College of Pharmacy, Chengdu University of TCM, Chengdu, Sichuan 611137, P.R. China.
Rong LiuDepartment of Pharmacology, College of Pharmacy, Chengdu University of TCM, Chengdu, Sichuan 611137, P.R. China.
Nan ZengDepartment of Pharmacology, College of Pharmacy, Chengdu University of TCM, Chengdu, Sichuan 611137, P.R. China.
Chengdu University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulegone is a key active component of Schizonepeta essential oil and has been determined to have anti-inflammatory properties. However, the underlying molecular mechanisms with regard to the NLR family pyrin domain containing 3 (NLRP3) inflammasome, also known as the NALP3 inflammasome, have remained to be elucidated. NLRP3 represents a potential link between inflammation and immunity and may play possible key role in various pathologies. In the present study, the modulatory effects of pulegone on the NLRP3 inflammasome were investigated. THP-1 cells induced with phorbol myristate acetate were divided into various groups, including the Normal (control), lipopolysaccharide (LPS), LPS + ATP/nigericin, LPS + ATP/nigericin + 0.2% DMSO and pulegone (0.2, 0.1 and 0.05 mg/ml) groups. ELISA was used to detect the levels of interleukin (IL)-1β and IL-18 in the cell supernatants and the influence of potassium ions was assessed. PCR was used to determine the expression levels of NLRP3, caspase-1, IL-1β and IL-1α in the cell lysates. Furthermore, NLRP3 and apoptosis-associated speck-like protein (ASC) were detected via immunofluorescence assays and fluorescence microscopy was employed to determine the reactive oxygen species (ROS) levels in the THP-1 cells. The results indicated reduced levels of IL-18 and IL-1β in the supernatant of the cells of the pulegone groups when compared with those in the LPS + ATP/nigericin group. In addition, reduced mRNA production of inflammasome-associated genes was detected in the cell lysates after pulegone treatment. The immunofluorescence analyses indicated significantly reduced protein expression levels of NLRP3 and ASC in the pulegone groups, as well as co-localization of the NLRP3 and ASC proteins. The pulegone groups also exhibited significantly reduced ROS levels. Furthermore, a high concentration of potassium ions significantly reduced the secretion of IL-1β after induction/stimulation. In conclusion, the present study suggested that pulegone exerts its anti-inflammatory effects on LPS + ATP/nigericin-induced THP-1 cells via inhibition of NLRP3 expression, and its regulatory mechanism is associated with potassium channel and ROS pathways. It was hypothesized that pulegone first inhibits ROS signaling, to then inhibit NLRP3 expression as a downstream event. It appeared that NLRP3 may be situated further downstream and represented the link between inflammation and immunity.

Indexed as

lipopolysaccharide + ATP/nigericinNLR family pyrin domain containing 3pulegoneTHP-1 cells

Identifiers

PMID32010303
PMCPMC6966169
OpenAlexW2996619281

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.